TP53 and neoplasm: ASPP1 and ASPP2 enhance the pro-apoptotic function of p53, promoting cell death in response to damage, while iASPP acts as a negative regulator, inhibiting apoptosis and thus potentially contributing to tumor progression (13, 14).